NCT05376566View on ClinicalTrials.gov

Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

April 1, 2026

Study Completion Date

June 15, 2026

Conditions
Central Line-associated Bloodstream Infection (CLABSI)
Interventions
DRUG

Hydrochloric Acid (2 M)

Hydrochloric acid (2 M) in a volume corresponding to dead space (0.3-1.8 ml) will be instilled and aspirated 10 min later; the instillation is completed 3 times.

DRUG

Normal saline

Normal saline in a volume corresponding to dead space (0.3-1.8 ml) will be instilled and aspirated 10 min later; the instillation is completed 3 times.

Trial Locations (4)

2100

RECRUITING

Department of Haematology, Copenhagen University Hospital, Copenhagen

RECRUITING

Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital, Copenhagen

3200

RECRUITING

Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus

4000

RECRUITING

Department of Paediatrics and Adolescent Medicine, Odense University Hospital, Odense

All Listed Sponsors
collaborator

Odense University Hospital

OTHER

collaborator

Aarhus University Hospital

OTHER

lead

Rigshospitalet, Denmark

OTHER